Selegiline, also known as 1-deprenyl, is an irreversible and selective monoamine oxidase-B (MAO-B) inhibitor and is administered alone or together with (S)-3,4-dihydroxyphenylalanine (L-DOPA) for the treatment of Parkinson's syndrome and Alzheimer's disease. [ 1 1. (a) Sterling , J. ; Herzing , Y. ; Goren , T. ; Finkelstein , N. ; Lerner , D. ; Glodenburg , W. ; Miskolczi , I. ; Molner , S. ; Rental , F. ; Tamas , T. ; Toth , G. ; Zagyva , A. ; Zekany , A. ; Lavina , G. ; Gross , A. ; ...
[Robinson, Philip L.; Barry, Carey N.; Kelly, Jeffery W.; Evans, Slayton A. Journal of the American Chemical Society, 1985 , vol. 107, # 18 p. 5210 - 5219]
